A computational framework for predicting potential regulators of Fog Signaling
Before we describe the computational methods we used to predict candidate Fog signaling regulators, we first built a comprehensive resource of Drosophila protein-protein interactions from the literature. This information can be represented as a protein-protein interactome, which describes a set of proteins and connections between those proteins. An interactome is mathematically formulated as a graph, where the nodes (proteins) are connected by edges (protein-protein interactions). We combined six existing Drosophila resources of protein-protein interaction data to build an interactome with 11,473 nodes and 233,054 undirected edges, ignoring self-loops and mapping all proteins to FlyBase identifiers (Table 1). Each edge in the interactome may be supported by multiple databases; while DroID contributes the largest amount of data, 10,654 edges (5%) are not supported by DroID and would be missed by a single-database analysis. Each edge in the interactome includes literature citations as well as sources of experimental or other evidence. In total, the interactions are supported by 21,065 pubmed-indexed literature citations and 58 PSI-MI evidence sources (Hermjakob et al., 2004).
Table 1. Data sources used to build the fly interactome.
Data Source
|
Data Source Type
|
# Interactionsa
|
FlyMine (Lyne et al., 2007)
|
Data warehouse for functional genomic & proteomic datasets.
|
278,370
|
DroID (Murali et al., 2011)
|
Experimentally detected interactions curated from literature and external databases.
|
262,179
|
Mentha (Calderone et al., 2013)
|
Experimentally detected physical interactions.
|
45,669
|
MyProteinNet (Basha et al., 2015)
|
Protein interaction data compiled from 11 PPI databases.
|
41,530
|
SignaLink 2 (Fazekas et al., 2013)
|
Protein interactions curated from literature, integration of interactions from PPI databases, and integration of transcription factors and their regulatory interactions.
|
5,236
|
FlyReactome (Matthews et al., 2009)
|
Expert-authored knowledgebase of reactions and pathways.
|
612
|
aAccessed fall of 2017.
Our computational goal was to identify candidates of NMII regulation by Fog signaling using this fly-specific interactome. We began by pooling three sets of proteins that are known to be relevant to Fog signaling (Manning et al., 2013), apical constriction (Gene Ontology 0003383), and gastrulation (Gene Ontology 0007369) to produce a list of 104 known protein regulators (called positives; Supplementary Table 2). Using the fly interactome, we applied three graph algorithms to identify protein candidates that are “near” the known protein regulators (Figure 1). The Steiner Tree Approximation method aims to connect the positives with as few edges as possible; candidates are nodes that are used to connect the positives. The Paths to NMII method calculates the shortest path from each positive to Sqh; candidates are nodes that are on these paths. Finally, the Ranked Paths method calculates, for each unlabeled node, the shortest path from each positive to that node and assigns a score that is proportional to the average length of the shortest path. All nodes in the Ranked Paths method are ranked; the nodes with a normalized score greater than 0.7 were selected as candidates (Figure 1A). See the Methods for more details about the graph algorithms employed.
There is surprisingly little overlap among the candidates from the three methods (Figure 1B). Only two candidates, Spinophilin (Spn) and Ubiquitin-63E (Ubi-p63E), were identified by all three methods. Depletion of Spn is known to inhibit cellular contractility as assessed by a cellular contractility assay (Allen et al., 1997, for details see below and Methods section) while depletion of Ubi-p63E led to apoptosis preventing further assessment (unpublished data). Nineteen candidates were identified by two or more methods, and a total of 88 protein candidates were identified by any of the methods (Supplementary Table 2). We excluded candidates that had already been shown to be a part of the Fog signaling pathway or were known Sqh interactors. As our contractility assay was performed in S2R+ cells we further excluded candidates that were not expressed in these cells according to Harvard Fly RNAi database (Hu et al., 2021). From this list of 88 candidates 14 proteins were selected as promising for follow-up study.
Preliminary screen of computational putative targets
Table 2. Preliminary screen of computational identified candidates.
Drosophila gene name
|
Symbola
|
CG Numberb
|
casein kinase IIα
|
CkIIalpha
|
CG17520
|
Ras opposite
|
Rop
|
CG15811
|
Meltrin
|
Meltrin
|
CG7649
|
14-3-3zeta
|
14-3-3zeta
|
CG17870
|
microtubule star
|
mts
|
CCG7109
|
CG10347
|
CG10347
|
CG10347
|
Kinesin heavy chain
|
Khc
|
CG7765
|
Tenascin major
|
Ten-m
|
CG5723
|
corkscrew
|
csw
|
CG3954
|
flapwing
|
flw
|
CG2096
|
seven in absentia
|
SinA
|
CG9949
|
downstream of receptor kinase
|
drk
|
CG6033
|
Calcineurin B2
|
CanB2
|
CG11217
|
groucho
|
gro
|
CG8384
|
aGene symbol from Flybase (Gramates et al., 2022).
bAnnotation symbol from Flybase (Gramates et al., 2022).
We initially screened all 14 candidates (Table 2) using a cellular contractility assay (Rogers et al., 2004; Peters et al., 2018), which capitalizes on the Fog-signaling pathway (Manning and Rogers, 2014). Briefly, this cell-based contractility assay uses exogenously expressed Fog-myc harvested from a stable S2:Fog-myc cell line, that, when applied to S2R+ cells, leads to the phosphorylation of Sqh via Rho1 signaling, leading to the contraction of cells (Rogers et al., 2004; Manning et al., 2013). Indicative of this contractility is the observation of phase-dark and phase-light ruffling or “bonneting” when imaged by phase-contrast microscopy (Figure 2 A & B). S2R+ cells were treated with RNAi for seven days and then challenged to contract. Following this initial screen we identified three candidates that failed to contract following perfusion with Fog. The PP1 catalytic subunit Flapwing (Flw), CG10347 which, according bioinformatic queries, is putatively a member of the heat shock protein (HSP) 20 family, and CG11811 (hereafter we refer to as Oya [oya]) which, according to bioinformatic queries and previous studies, is a guanylate kinase (Funke et al., 2005; Zhang et al., 2011). We have subsequently named CG11811 the putative Drosophila guanylate kinase, Oya after the Yoruba goddess of water who is associated with fertility and acts of creation.
Using an identical protocol we performed a secondary screen focused on these three candidates. This screen revealed that cells depleted of CG10347 still contracted, with the fraction of contracted cells following the addition of Fog not statistically different from that of control RNAi treated cells (Figure 2A-D, & I), while cells depleted of Flw and Oya failed to substantially contract following perfusion with Fog (p value < 0.0001, Student’s t-test, N=3, n= 54-129 image fields per condition) (Figure 2E-H, J & K). Given that the RNAi depletion CG10347 failed to inhibit contractility in this assay we decided to no longer pursue this candidate.
To determine the efficacy of our RNAi depletion, we performed three independent rounds of reverse transcription quantitative PCR (RT-qPCR) to determine the transcriptional abundance of either flw or oya in our RNAi treated cells. Cells treated with either flw, oya, or oya 5’-untranslated region (UTR) RNAi were compared against control treated cells using elongation factor-1 (ef1) as an internal reference (Figure 2L & M). The RT-qPCR data showed a statistically significant decrease in flw mRNA as compared to control RNAi treated samples (p-value < 0.001, Student’s t-test, N = 3) (Figure 1L). Similarly, in cells treated with dsRNA directed against either coding region or 5’ UTR of oya we observed a statistically significant decrease in oya mRNA as compared to control RNAi treated samples albeit, the dsRNA targeting the coding region showed a far more substantial decrease (p-value = 0.0024, and p-value > 0.0001 for 5’UTR and the coding region dsRNA respectively, ANOVA, N = 5). Given the results of initial contractility assay and efficacy of our RNAi we decided to explore further how the depletion of Flw and Oya can lead to a decrease in NMII contractility.
Oya Depletion Affects the Abundance and Spatial Distribution of Phosphomyosin
In order to further probe the hypocontractility observed upon depletion of CG1181, we investigated both the abundance and spatial distribution of phosphomyosin in CG1181 depleted cells. To this end, cells were treated with either control, Oya, or Sqh RNAi for seven days and then challenged to contract by perfusion of Fog-enriched media. We then immunostained the cells with an antibody raised against a synthetic phosphopeptide mimicking phosphorylated NMII (Platenkamp et al., 2020) as well as fluorescently-labeled phalloidin to visualize actin filaments (Figure 3A-C). Imaging the cells by epifluorescence microscopy, we quantified the phosphomyosin staining following the Fog and RNAi treatments (Figure 3D & E). This analysis revealed that Oya depleted cells have levels of phosphomyosin that are significantly lower than those of control treated cells but greater than that of Sqh RNAi treated cells (p-value <0.00062, ordinary one-way ANOVA, N=3, n= 289-510 cells) (Figure 3D). Taking the fluorescence as an assay of phosphomyosin abundance, such a result suggests that, upon Fog induction, the amount of active, phosphorylated myosin is reduced in Oya depleted cells, likely contributing to cellular hypocontractility. However, Oya depletion does not completely inhibit the phosphorylation of the regulatory light chain, as evidenced by the significantly higher fluorescence values compared to Sqh depleted cells.
We then turned to probing the effects of Oya knockdown on the spatial distribution of phosphomyosin. Following Fog treatment in S2R+ cells the NMII network reorganizes assembling into ordered peri-nuclear structures such as rings which are highly reminiscent of medioapical polarization observed in epithelial cells in vivo (Coravos and Martin, 2016). In order to quantify NMII distribution we used a previously established coalescence index (Bouchier-Hayes et al., 2008; Platenkamp et al., 2020). The higher coalescence index value the more organized (or less diffuse) the actomyosin network. This analysis reveals that Oya depletion results in a phosphomyosin distribution pattern significantly more diffuse than control RNAi treated cells yet more ordered than Sqh RNAi treated cells, mirroring the same pattern we observed in quantifying the amount of phosphomyosin (p-value = 0.002947, Ordinary one-way ANOVA, N=3, n=135-161 cells) (Figure 3E). Thus, phosphomyosin distribution of Oya treated cells presented an “intermediate” phenotype where certain cells (Figure 3B, yellow arrows) managed to recruit the ring of phosphomyosin seen in control treated cells while others displayed diffuse patterns of phosphomyosin (Figure 3B, red arrows) similar to Sqh dsRNA treated cells. In addition we also imaged the distribution of EGFP-tagged Sqh in live cells following control, Oya, or Sqh dsRNA treatment (Supplemental Figure 1A-D). Similar to our phosphmyosin staining, we observed an intermediate, diffuse pattern of Sqh-EGFP following Oya depletion whereas a clear perinuclear organization of Sqh can be observed in control depleted cells (Supplementary Figure 1A, C & D). Depletion of Sqh led to a highly diffuse NMII pattern as expected (Supplementary Figure 1B). Together, Oya knockdown appears to have a moderate effect on the recruitment and organization of NMII filaments, reducing the abundance of phosphomyosin while inhibiting the assembly of higher-order myosin structures which is likely contributing to the hypocontractility phenotype we observed in contractility assay.
Depletion of Oya may alter cytoplasmic concentrations GTP
Previous studies suggested Oya is a putative guanylate kinase due to its sequence similarity with mammalian guanylate kinases as well as its ability to phosphorylate GMP and dGMP using ATP as a phosphate donor(Johansson et al., 2005). Considering that depletion of guanylate kinases has been demonstrated to decrease intracellular concentrations of both GDP and GTP (Cai et al.,) as well as the centrality of GTP-mediated signaling in the Fog pathway via the Rho family of GTPases, we hypothesized that Oya’s regulation of the pathway could be due its putative role in regulating intracellular GTP levels. To test this hypothesis, we treated cells with control or Oya RNAi, or treated them with Mizoribine selective inhibitor of inosine-5'-monophosphate dehydrogenase (IMPDH) and guanosine monophosphate synthetase as a control and then fixed and stained the cells with an anti-tubulin antibody (Supplemental Figure 2). Given the importance of GTP-tubulin to the formation of microtubules, changes to microtubule fluorescence intensity would be an indicator of cytoplasmic GTP levels. We quantified anti-tubulin fluorescence intensity and found that both treatment with Oya RNAi and Mizoribine led to a statistically significant decrease in tubulin staining as compared to control treated samples (p-value = 0.0001 One-way ANOVA, n = 38-84 cells) (Supplemental Figure 2). Further, Oya RNAi and Mizoribine treated cells were statistically indistinguishable suggesting that RNAi Oya affects the incorporation of tubulin subunits into microtubules possibly through lowering cytoplasmic GTP levels. In terms of the NMII contractility and the Fog pathway, decreased cytoplasmic levels could affect the function of Rho family GTPases. This possibility warrants further exploration but is beyond the scope of this study. For the remainder of this study we shifted our focus to the PP1 complex component Flw.
Depletion of other PP1 components does not phenocopy depletion of Flapwing
Nurse cells mutant for flw exhibited hyper-contracted ring canals (Yamamoto et al., 2013), and thus our results from the cellular contractility assay (Figure 1E, F, & J) are seemingly contradictory given that PP1 complex is commonly understood to function as phosphatase for targets such as the regulatory light chain of NMII. In order to further interrogate role of the PP1 complex in cellular contractility, we turned our attention to myosin binding subunit (MBS) and myosin phosphatase targeting subunit 75D (MYPT-75D) which are both involved in the targeting of the PP1 complex(Yong et al., 2006; Grassie et al., 2011; Vasquez et al., 2014). MYPT-75D contains a prenylation motif suggesting that it may be involved in membrane targeting while MBS lacks this prenylation. We depleted MBS, MYPT-75D, and Flw, as well as Flw and MBS, and Flw and MYPT-75D in combination, and following our cellular contractility assay, challenged the cells to contract upon the addition of Fog (Figure 4A-G). We again observed a statistically significant inhibition of cellular contractility following the addition of Fog in cells depleted of Flw as compared to control RNAi treated cells (p-value < 0.0001, ANOVA, N = 3-4, n = 50-75 cells) however, depletion of MBS failed to inhibit contractility and was no different from control RNAi treated samples (Figure 4A-C & H). Depletion of MYPT-75D yielded mixed phenotype, with the fraction of cells undergoing contractility following the addition of Fog being statistically different from both control RNAi treated cells and that of Flw RNAi treated cells (p-values = 0.0389 and <0.0001 respectively, ANOVA N = 3, n = 25-40 image fields) (Figure 4A-E & H). Double depletion of Flw and MBS and Flw and MYPT-75D did lead to a slight rescue, with the fraction of contracted cells following Fog perfusion being statistically significant from both Flw RNAi (p-value = 0.004 and 0.0017, respectively ANOVA, N = 3, n = 25-40 image fields), but this rescue was incomplete as these RNAi conditions were as also statistically different from control RNAi treated cells (p-value < 0.0001, ANOVA, N = 3, n = 25-40 image fields) (Figure 4A-H). These results indicate that despite potentially being a part of the same complex, the targeting subunits, MBS and MYPT-75D, and the catalytic subunit, Flw play differential roles in regulating the contractility of cells.
An additional phenotype observed in Flw depleted cells is their failure to spread on con A coated coverslips. These cells appeared to be backlit and displayed smaller circumferences (Figure 4A-G). This rounded phenotype was previously observed in the wing imaginal disc cells of flw mutants; notably, these cells also displayed partial colocalization between the junction complexes Coracle, Armadillo and F-actin, indicating a loss of apical-basal polarity (Yang et al., 2012). We quantified the number of rounded cells we observed following RNAi treatment with Flw, MBS, MYPT-75D, and the combination of Flw and MBS and Flw and MYPT-75D, and compared them to control RNAi treated cells following Fog perfusion. We found that depletion of Flw indeed led to a significant increase in the number of rounded cells (p-value < 0.0001, ANOVA, N = 3, n = 25-40 image fields), while number of rounded cells following depletion of MBS and MYPT-75D was no different from control RNAi treated cells (Figure 4A-G & I). Double depletion of Flw and MBS and Flw and MYPT-75D increased the number of rounded cells, indicative of Flw’s penetrance (Figure 4F, G, & I). These results closely mirror that of our contractility assay and again point to differences in the regulation of cellular contractility between PP1 components.
Flapwing, MYPT-75D, and MBS have distinct localization patterns and differentially regulate phosphomyosin distribution
NMII generated contractility relies on the concerted phosphorylation of the regulatory light chain, which results in a conformational change to the overall NMII holoenzyme allowing for oligomerization and the subsequent binding and contraction of actin filaments. Traditionally, the activity of phosphatases such as the PP1 complex, opposes this phosphorylation and maintains the NMII holoenzyme in the “closed” conformation. Previously it has been reported that MYPT-75D localizes to the cell membrane (Vereshchagina et al., 2004) while MBS can be found throughout the cytoplasm (Grassie et al., 2011). As it is likely that these spatial differences add yet another level of regulation, we sought to determine if these localization patterns are consistent in S2R+ cells (Figure 5). Consistently, we observed Flw forming a ring inside the peri-nuclear network of NMII in the center of these cells (Figure 5A). This is in contrast to MBS, which rather than forming a distinct ring, could be found in the center of the this peri-nuclear NMII ring as an amorphous cloud (Figure 5B), while MYPT-75D had a more global localization pattern forming a haze throughout the cytoplasm (Figure 5C). Thus, it appears that there are differences in localization between these components of the PP1 complex which may translate to differences in the regulation of NMII contractility.
The distinct localization of PP1 complex proteins likely influences the spatiotemporal distribution of phosphorylated NMII regulatory light chain, and thus cellular contractility. To interrogate the distribution of phosphorylated NMII regulatory light chain we depleted S2R+ cells of Flw, MBS, MYPT-75D or treated them with control RNAi, and then immunostained them using an anti-phosphomyosin antibody we previously used (Figure 6A-D). Following fixation and immunostaining we imaged and quantified the mean fluorescence pixel intensity of cells depleted of Flw, MBS, MYPT-75D or treated control RNAi in the absence of Fog in order to obtain a basal phosphorylation rate (Figure 6A-E). We found that depletion of both Flw and MYPT-75D lead to a statistically significant increase in phosphomyosin staining as compared to control or MBS RNAi conditions (p-value <0.0001, ANOVA, n = 30-57 cells) (Figure 6E). The observed hypocontractility, when viewed in conjunction with the increased abundance of phosphorylated myosin, suggests that Flw depleted cells might display defects in spatial or temporal regulation NMII. In order to explore this latter possibility we decided to quantify the spatial distribution of the phosphorylated regulatory light chain using our coalescence index (Bouchier-Hayes et al., 2008; Platenkamp et al., 2020). Again, the greater the coalescence index the more punctate the distribution which in turn indicates a more organized phosphomyosin network. This analysis revealed that while being statistically indistinguishable between one another, the phosphomyosin distribution of Flw or MYPT-75D was significantly more diffuse than MBS or control RNAi treated cells (p-value < 0.0001, ANOVA, n = 25-108 cells) both with and without the perfusion of Fog (Figure 6G & H). The Fog pathway has been previously investigated in S2R+ cells, where it was observed that the addition of Fog and the subsequent contractility coincided with a "purse string" structure of NMII circling the organelle-rich center domain of the cell. The contraction of this circular structure resulted in the "bonneted" morphology of S2R+ cells plated on con A (Figure 2B) (Rogers et al 2004). Another proxy for the coalescence index is the prevalence of this phosphomyosin ring. In control treated cells, upon addition of Fog, we observed defined rings of phosphorylated myosin surrounding the central region of the cell (Figure 6A), consistent with the literature. However, in Flw depleted cells, we saw a significant decrease in the proportion of cells displaying defined rings of phosphomyosin following Fog addition as compared to control, MBS, and MYPT-75D RNAi treated cells (p-value < 0.0001, one-way ANOVA, n = 29-89 image fields) (Figure 6B, & F). Thus, the depletion of either Flw or MYPT-75D results in an increase in the phosphorylation state of the regulatory light chain network but a decrease in its organization. Further, given some of the overlap in phenotypes, it may suggest a larger role for MYPT-75D in targeting Flw over MBS in these cells. These results also indicate that increased phosphorylation of the regulatory light chain is not enough to induce cellular contractility; it must also be spatially organized as well.
Loss of Contractility Following Flapwing Depletion is Partially Mediated through Moesin Activity
Flw is known to be able to dephosphorylate and thus inactivate the Ezrin-Radixin-Moesin (ERM) protein Moesin (Yang et al., 2012). Considering that Moesin has been implicated in driving cellular rounding (Kunda, Pelling, Liu, Baum et al.,2008), a phenotype observed in Flw depleted cells, we hypothesized that the phenotypes observed upon Flw knockdown could be due to an increased abundance of phosphorylated, active, Moesin. In order to test this hypothesis, S2R+ cells were depleted of Moesin, Flw, and Flw and Moesin in combination or were treated with control RNAi and then were challenged to contract following perfusion of Fog (Figure 7). Depletion of Moesin led to a hypercontractile phenotype, with a larger fraction of cells undergoing Fog-induced contractility than control RNAi treated cells (p-value = 0.00230, One-way ANOVA, N = 3). This finding may be indicative of less resistance to NMII contractility as depletion of Moesin is likely leading to inability of the cortical actin network to maintain tension. Additionally, the hypocontractile phenotype in Flw depleted cells was partially rescued by the double depletion of Flw and Moesin (p-value = 0.001634, One-way ANOVA N = 3). We also quantified the fraction of rounded cells following treatment with control, Moesin, Flw, and Moesin and Flw RNAi and observed a trend similar to our contractility assay. Moesin depleted cells were no different than control RNA depleted cells, and Flw RNAi led to stark increase in the fraction of rounded cells which was as compared to Moesin and control RNAi treated cells (p-value <0.0001, One-way ANOVA, N = 3). However, the fraction of rounded cells failed to be rescued by depletion of Moesin and Flw in tandem. Collectively, these results indicate an antagonistic relationship between Moesin and Flw and may suggest that the hypocontractility we observed following Flw may be the result of increased cortical tension, a consequence of hyperphosphorylated Moesin. This increased tension and the loss of spatial resolution of the phosphorylated regulatory light chain of NMII is enough to inhibit contractility in our assay following Flw RNAi.
To further interrogate how the phosphorylation state of Moesin affects contractility, likely through regulating cortical tension, we generated both phosphomimetic (T559E) and non-phosphorylatable Moesin point mutants (T559A) and then tested them in our contractility assay. We depleted the endogenous pool of Moesin by using dsRNA generated against the 3’-untranslated region (UTR) of Moesin and then transiently expressed EGFP-tagged Moesin-T559A and -T559E which are refractory to this dsRNA. The cells were then subjected to the aforementioned cellular constriction assay. Cells expressing phosphomimetic Moesin failed to constrict in response to Fog induction and displayed increased proportions of rounded cells, recapitulating the phenotype observed upon treatment with Flw dsRNA. Together, these results suggest that Flw’s regulation of cellular contraction is mediated, in part, through the increased abundance of active Moesin following Flw knockdown.
Phosphomyosin Abundance and Distribution is Perturbed by Phospho-mimetic Moesin Mutants
Having demonstrated that the phosphorylation state of Moesin impacts cellular contractility, we then aimed to investigate if this phenotype was the result of aberrations in phosphomyosin abundance and distribution. To this end, we treated cells with either control or Moesin 3’UTR dsRNA and then transiently expressed fluorescently tagged phosphomimetic and non-phosphorylatable Moesin mutants. Cells were then stimulated with Fog-conditioned before immunostaining with the aforementioned phosphomyosin antibody. This immunostaining revealed that cells depleted of Moesin displayed the characteristic rings of phospho-myosin seen in control cells and referenced previously. The expression of non-phosphorylatable Moesin-T559A did not impair the formation of these myosin rings while the expression of the phosphomimetic T559E Moesin mutant resulted in a more diffuse distribution of phosphomyosin, with atypical concentrations around the cellular cortex. Statistical analysis revealed a significant decrease in both the abundance and coalescence index of phosphorylated NMII in cells expressing the T559E Moesin mutant, suggesting that phosphorylated Moesin can inhibit the recruitment and higher-order assembly of phosphomyosin. This phenotype could be the result of Moesin’s known function as an antagonist to Rho pathway (Speck et al., 2003) as the phosphorylation of NMII by Rok is triggered by signaling from Rho1.
Considering that Flw knockdown results in increased amounts of phosphorylated, active Moesin, we would expect to see a decrease in phosphomyosin abundance in Flw depleted cells, similar to the phosphomimetic mutant expressing cells, rather than the observed increase. This apparent contradiction suggests that Flw directly regulates the phosphorylation state of NMII, as the increase in phosphomyosin abundance cannot be accounted for by regulation of Moesin alone. Together, these observations suggest that Flw regulates cellular contractility through both Moesin-mediated and Moesin-independent mechanisms.